Bryn Mawr Trust CO Amgen Inc Transaction History

Bryn Mawr Trust CO

$5.48 Billion
Q3 2024

A detailed history of Bryn Mawr Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Bryn Mawr Trust CO holds 65,201 shares of AMGN stock, worth $17.2 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

65,201

Previous 59,453 9.67%

Holding current value

$17.2 Million

Previous $18.6 Million 13.09%

% of portfolio

0.38%

Previous 0.73%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	BUY	$309.38 - $337.38 $1.78 Million - $1.94 Million	5,748 Added 9.67%	65,201 $21 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $193,646 - $235,331	-737 Reduced 1.22%	59,453 $18.6 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $387,710 - $468,015	-1,442 Reduced 2.34%	60,190 $17.1 Million
Q3 2023 Nov 15, 2023	SELL	$218.65 - $271.46 $14,430 - $17,916	-66 Reduced 0.11%	61,632 $16.6 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $121,705 - $143,914	568 Added 0.93%	61,698 $13.7 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $86,703 - $105,676	384 Added 0.63%	61,130 $14.8 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $121,843 - $154,817	-532 Reduced 0.87%	60,746 $16 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $637,690 - $719,199	-2,841 Reduced 4.43%	61,278 $13.8 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $648,756 - $721,952	-2,812 Reduced 4.2%	64,119 $15.6 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1.31 Million - $1.45 Million	-5,992 Reduced 8.22%	66,931 $16.2 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $198,880 - $227,600	-1,000 Reduced 1.35%	72,923 $16.4 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $206,750 - $242,233	-974 Reduced 1.3%	73,923 $15.7 Million
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $70,307 - $78,001	-301 Reduced 0.4%	74,897 $18.3 Million
Q1 2021 Apr 23, 2021	SELL	$221.91 - $258.6 $780,679 - $909,754	-3,518 Reduced 4.47%	75,198 $18.7 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $315,049 - $375,167	-1,456 Reduced 1.82%	78,716 $18.1 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $750,880 - $835,040	-3,200 Reduced 3.84%	80,172 $20.4 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $2.49 Million - $3.05 Million	-12,575 Reduced 13.11%	83,372 $19.7 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $831,743 - $1.1 Million	4,564 Added 4.99%	95,947 $19.5 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $263,569 - $338,777	-1,393 Reduced 1.5%	91,383 $22 Million
Q3 2019 Oct 24, 2019	SELL	$174.11 - $208.62 $39,522 - $47,356	-227 Reduced 0.24%	92,776 $18 Million
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $121,190 - $142,063	727 Added 0.79%	93,003 $17.1 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $199,318 - $224,675	1,102 Added 1.21%	92,276 $17.5 Million
Q4 2018 Aug 28, 2019	BUY	$178.4 - $208.25 $124,880 - $145,775	700 Added 0.77%	91,174 $17.7 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $4.29 Million - $5.01 Million	24,034 Added 36.17%	90,474 $17.6 Million
Q3 2018 Aug 28, 2019	BUY	$185.29 - $208.89 $129,703 - $146,223	700 Added 1.06%	66,440 $13.8 Million
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $183,251 - $206,592	-989 Reduced 1.48%	65,740 $13.6 Million
Q2 2018 Aug 28, 2019	BUY	$166.05 - $186.51 $116,235 - $130,557	700 Added 1.06%	66,729 $12.3 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $100,792 - $113,211	607 Added 0.93%	66,029 $12.2 Million
Q1 2018 Aug 28, 2019	BUY	$169.43 - $198.0 $118,601 - $138,600	700 Added 1.08%	65,422 $11.2 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $291,080 - $340,164	-1,718 Reduced 2.59%	64,722 $11 Million
Q4 2017 Aug 28, 2019	BUY	$168.79 - $188.59 $113,764 - $127,109	674 Added 1.02%	66,440 $11.6 Million
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $203,729 - $227,628	-1,207 Reduced 1.8%	65,766 $11.4 Million
Q3 2017 Aug 28, 2019	SELL	$167.29 - $191.0 $396,477 - $452,670	-2,370 Reduced 3.42%	66,973 $12.5 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $11.6 Million - $13.2 Million	69,343	69,343 $12.9 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Amgen Inc Transaction History